PetMed Express, Inc. (NASDAQ:PETS) announced a quarterly dividend on Monday, July 24th, RTT News reports. Investors of record on Monday, August 7th will be given a dividend of 0.20 per share on Friday, August 18th. This represents a $0.80 annualized dividend and a dividend yield of 1.81%. The ex-dividend date is Thursday, August 3rd.
Shares of PetMed Express (NASDAQ PETS) traded down 2.57% during trading on Friday, reaching $44.29. 1,568,167 shares of the company’s stock were exchanged. The stock has a 50-day moving average price of $44.29 and a 200 day moving average price of $30.92. PetMed Express has a 12-month low of $18.90 and a 12-month high of $50.90. The company has a market capitalization of $898.73 million, a P/E ratio of 34.07 and a beta of 0.99.
PetMed Express (NASDAQ:PETS) last issued its quarterly earnings results on Monday, July 24th. The company reported $0.45 EPS for the quarter, beating analysts’ consensus estimates of $0.38 by $0.07. The firm had revenue of $79.66 million during the quarter, compared to the consensus estimate of $77.32 million. PetMed Express had a return on equity of 28.67% and a net margin of 10.34%. PetMed Express’s revenue for the quarter was up 9.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.32 earnings per share. Equities analysts expect that PetMed Express will post $1.44 EPS for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: “PetMed Express, Inc. Declares Quarterly Dividend of $0.20 (NASDAQ:PETS)” was originally published by BNB Daily and is owned by of BNB Daily. If you are reading this story on another publication, it was illegally stolen and republished in violation of US & international trademark and copyright law. The legal version of this story can be read at https://www.baseball-news-blog.com/2017/08/19/petmed-express-inc-announces-quarterly-dividend-of-0-20-nasdaqpets-updated-updated-updated.html.
A number of research analysts recently commented on PETS shares. Zacks Investment Research raised PetMed Express from a “hold” rating to a “strong-buy” rating and set a $38.00 price target for the company in a report on Wednesday, May 10th. Northcoast Research upgraded PetMed Express from a “neutral” rating to a “buy” rating and set a $54.00 price target on the stock in a research report on Monday, July 24th. Craig Hallum cut PetMed Express from a “buy” rating to a “hold” rating in a research report on Tuesday, July 11th. Finally, Noble Financial reiterated a “hold” rating on shares of PetMed Express in a research report on Wednesday, July 26th.
In other news, Director Robert C. Schweitzer sold 2,500 shares of the firm’s stock in a transaction on Tuesday, August 1st. The stock was sold at an average price of $49.18, for a total transaction of $122,950.00. Following the completion of the sale, the director now directly owns 88,834 shares of the company’s stock, valued at approximately $4,368,856.12. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO Bruce S. Rosenbloom sold 6,833 shares of the firm’s stock in a transaction on Thursday, July 27th. The stock was sold at an average price of $50.18, for a total value of $342,879.94. Following the sale, the chief financial officer now directly owns 18,534 shares of the company’s stock, valued at $930,036.12. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 19,333 shares of company stock valued at $949,730. 4.00% of the stock is currently owned by corporate insiders.
PetMed Express Company Profile
PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.
Receive News & Ratings for PetMed Express Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express Inc. and related companies with MarketBeat.com's FREE daily email newsletter.